✨ Free AI Report
Arteriocyte Medical Technologies: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Arteriocyte Medical Technologies
Company Research

Arteriocyte Medical Technologies: Business Overview, Financials & Competitive Analysis

Arteriocyte Medical Technologies is a regenerative medicine company focused on stem cell and tissue engineering-based therapies. The company develops point-of-care medical devices and cellular concentrates for orthope...

Analyst-debate audio for Arteriocyte Medical Technologies

AskCyborg analysts argue the bull and bear cases for Arteriocyte Medical Technologies across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
4/ 10Weak

Cyborg Score thesis

Legacy regenerative medicine player with proven technology but unclear current status and market relevance...

Read the full analyst-debate transcript →
Industry Medical Devices
3 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Arteriocyte Medical Technologies Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Arteriocyte Medical Technologies Overview

Pro stress-test →

Arteriocyte Medical Technologies is a regenerative medicine company focused on stem cell and tissue engineering-based therapies. The company develops point-of-care medical devices and cellular concentrates for orthopedic, cardiac, and vascular applications.

Strategic Profile

Pro stress-test →

Arteriocyte pioneered bedside cell therapy systems including the Magellan platform for rapid production of platelet-rich plasma and bone marrow-derived cellular concentrates. The company has pursued clinical development in orthopedic trauma and critical limb ischemia with partnerships including the U.S. Army Institute of Surgical Research.

Competitive Landscape

Pro stress-test →

Arteriocyte competes in the regenerative medicine and point-of-care cell therapy device space. Competitors include broader regenerative medicine companies and orthopedic implant manufacturers developing cell-based solutions.

Industry Context

Arteriocyte Medical Technologies operates in Medical Devices.

Key facts

Founded: 2004 · Headquarters: Cleveland, US · Employees: 51-100 · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Arteriocyte Medical Technologies.

  • Magellan system is FDA 510(k) cleared for point-of-care production of platelet-rich plasma and bone marrow concentrate
  • Acquired by ISTO Technologies in October 2016 and integrated into Isto Biologics platform
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • June 2011Cooperative Research and Development Agreement (CRADA) signed with U.S. Army Institute of Surgical Research for cellular therapies in orthopedic trauma
  • October 2016Acquired by ISTO Technologies and integrated into Isto Biologics
Get alerted when Arteriocyte Medical Technologies has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

InvitroGen/GibcoCell culture and regenerative medicine research products→Zimmer Orthopedic BiologicsOrthopedic and regenerative biology solutions→RTI BiologicsRegenerative tissue products for surgery→

Compare Arteriocyte Medical Technologies with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Arteriocyte Medical Technologies operates in Medical Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices research →
NEW · MCP server

Ask your AI assistant about Arteriocyte Medical Technologies

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Arteriocyte Medical Technologies and its top competitor on Cyborg Score”
“What did Arteriocyte Medical Technologies do this quarter?”
“Is Arteriocyte Medical Technologies a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Arteriocyte Medical Technologies do?+
Arteriocyte Medical Technologies is a regenerative medicine company focused on stem cell and tissue engineering-based therapies. The company develops point-of-care medical devices and cellular concentrates for orthope...
What is Arteriocyte Medical Technologies's Cyborg Score?+
Arteriocyte Medical Technologies has a Cyborg Score of 4/10 (Weak). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Arteriocyte Medical Technologies's main competitors?+
Named competitors include InvitroGen/Gibco, Zimmer Orthopedic Biologics, RTI Biologics. The full competitive landscape is in the AskCyborg report.
How can I get the full Arteriocyte Medical Technologies research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Arteriocyte Medical Technologies research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Arteriocyte Medical Technologies over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Medical Devices research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Ambu A/S6Anika Therapeutics, Inc.6Pulse Biosciences, Inc.6Supermax Corporation Berhad5PolyNovo Limited4Know Labs, Inc.3SeaStar Medical Holding Corporation2Talis Biomedical Corporation